Cameco Corporation (CCJ) Up 4.5% — Time to Shift From Cash to Shares?

  • CCJ rose 4.52% to $121.39 from $116.14 previous close
  • Weiss Ratings assigns B (Buy)
  • Market cap is $50.64B

Cameco Corporation (CCJ) extended its strong performance on the NYSE, advancing 4.52% from the prior close. The stock finished at $121.39, gaining $5.25 from $116.14 in a session marked by sustained bullish activity — shares pressed higher throughout the day rather than surrendering early gains. The latest move reinforces the positive momentum CCJ has been building, with steady follow-through signaling that buyers remain committed to supporting higher prices.

Trading volume came in at 2,253,918 shares, running below the 90-day average of 4,497,062. Even on lighter turnover, the price action held firm — suggesting the advance was driven by genuine conviction rather than a surge in heavy trading. CCJ is also closing in on its 52-week high, with the current price sitting just $13.85, or roughly 10.2%, below the $135.24 peak reached on 01/29/2026. That proximity to recent highs keeps the broader uptrend intact and within reach.

Within the broader Energy landscape, CCJ's advance stands out both for its pace and persistence. Many large-cap names like Enbridge (ENB), Kinder Morgan (KMI), and The Williams Companies (WMB) tend to move more gradually from session to session, yet CCJ has shown a consistent ability to post decisive percentage gains when momentum turns constructive. The latest session adds another positive data point to its recent track record, with price strength doing the heavy lifting and keeping the chart pointed higher.


Why Cameco Corporation Price is Moving Higher

Cameco Corporation (CCJ) is drawing renewed investor interest as analysts maintain a broadly bullish stance on the uranium leader, with recent price target ranges clustering around $132–$136 and broader Wall Street estimates reaching as high as $161. That upbeat sentiment is sustaining momentum even in the absence of a headline-grabbing corporate catalyst. The market increasingly views Cameco as a premier vehicle for gaining exposure to nuclear fuel demand — a perception bolstered by its diversified position spanning uranium operations and its strategic stake in Westinghouse. In a sector where supply security commands a premium, that combination underpins a higher valuation as investors price in durable, long-term cash-flow potential.

Recent results continue to support the constructive outlook. Q4 2025 delivered a sharp improvement in profitability, with earnings per share rising 45% and revenue reaching a record $881.9 million. Quarterly revenue growth of 1.92% points to steady expansion rather than a one-off spike. Equally important for long-term confidence, Cameco's contract coverage extending through 2030 reduces revenue uncertainty and strengthens the investment case for institutions that need clear visibility in a cyclical commodity market.

The forward narrative remains compelling: analysts are focused on tightening uranium market fundamentals, planned production expansions at Cigar Lake and McArthur River, and the continued buildout of nuclear power as utilities seek reliable baseload generation. Cameco is increasingly recognized as a differentiated "energy transition" beneficiary, a distinction that sustains bullish sentiment and keeps buyers engaged.


What is the Cameco Corporation Rating - Should I Buy?

Weiss Ratings assigns CCJ a B rating, with a current recommendation of Buy. That overall grade places Cameco Corporation in a favorable risk/reward bracket, anchored by strength in the areas that matter most to longer-term investors: business momentum and balance-sheet quality. In particular, the Excellent Growth Index and Excellent Solvency Index carry much of the weight, helping offset components of the profile that remain more mixed.

On the operational side, CCJ's fundamentals reflect a company that can reliably convert demand into profitability, with a 16.98% profit margin and 1.92% revenue growth. The Good Efficiency Index is consistent with a solid — if not exceptional — 8.95% ROE, indicating that the company is generating reasonable returns on shareholder capital. The Good Total Return Index signals that performance has generally held up well on a risk-adjusted basis, which is a meaningful consideration when investors are weighing upside potential against the risk of drawdowns.

The primary trade-off lies in valuation and price variability. A forward P/E of 120.12 sets a demanding bar for future execution, and the Fair Volatility Index suggests investors should be prepared for swings that can be more pronounced than those of steadier large-cap income names. Even so, CCJ's B (Buy) rating reflects that, on balance, the overall profile remains attractive after accounting for those risks.

Within the Energy sector, Cameco compares favorably with other B-rated peers, including Enbridge Inc. (ENB, B) and Kinder Morgan, Inc. (KMI, B). It also sits in close company with The Williams Companies, Inc. (WMB, B), reinforcing that CCJ is well-positioned among the higher-rated names in the sector.


About Cameco Corporation

Cameco Corporation (CCJ) is a leading nuclear fuel supplier within the Energy sector, focused on producing and marketing uranium and fuel services for the global nuclear power industry. The company's core operations encompass uranium mining and milling, backed by a portfolio of long-life assets and deep technical expertise across the nuclear fuel cycle. Cameco also conducts contracting and marketing activities that connect its production and supply capabilities with utility customers seeking secure, reliable sources of nuclear fuel.

A cornerstone of Cameco's platform is its fuel services business, which provides conversion and related services that advance uranium from mined material into forms suitable for nuclear fuel fabrication. This end-to-end participation across supply and services deepens customer relationships and enhances the company's ability to manage operational and logistical requirements within a tightly regulated industry. Cameco's experience operating across jurisdictions with established regulatory frameworks — combined with its emphasis on safety, environmental stewardship, and quality assurance — is central to its standing among nuclear utilities and other industry stakeholders.

Cameco is also recognized for its broad global commercial reach, serving customers across multiple regions and participating in the long-term supply arrangements that are standard practice in nuclear fuel procurement. Scale, an established operating track record, and specialized infrastructure represent durable competitive advantages in uranium and fuel services, where reliability and regulatory compliance are non-negotiable.


Investor Outlook

Cameco Corporation (CCJ) carries a Weiss Rating of B (Buy), pointing to a favorable risk/reward profile and the potential for continued gains if recent momentum holds. Investors would do well to monitor whether shares can build on the latest advance and how broader sentiment around energy and uranium evolves, as shifts in either can influence near-term direction. It is also worth tracking whether the factors underpinning the B (Buy) rating remain intact as market conditions change. See full rankings of all B-rated Energy stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $177.39
B
AAPL NASDAQ $255.92
B
AVGO NASDAQ $314.55
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $125.79
B
B
Top Financial Stocks
See All »
B
B
JPM NYSE $293.10
B
V NYSE $300.80
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $935.58
B
JNJ NYSE $243.04
B
AMGN NASDAQ $347.94
Top Real Estate Stocks
See All »
B
PLD NYSE $133.77